CTRI/2022/07/044475尚未招募未知
Role of Repeat Injection Ranibizumab in Management of Aggressive Retinopathy of Prematurity (AROP) in Preterm Neonates: Randomized Control Trial
Janani Shishu Suraksha Karyakram0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Gestational age < 34 weeks (or higher with risk factors for ROP)
- •2. Birth weight < 2000 gram (or higher with risk factors for ROP)
- •3. Bilateral Zone 1 or Zone 2 Posterior AROP
- •4. No previous treatment
- •5. Clear media suitable for documentation and treatment
- •6. Pediatrician assesses the neonate to be fit enough for the procedure
排除标准
- •1. Reactivation before 6 weeks after first dose of Ranibizumab
- •2. Parents unwilling for consent
- •3. Parents not willing for regular and complete follow up
研究者
相似试验
招募中
1 期
ong-term need of Ranibizumab injections with or without early targeted peripheral laser photocoagulation for treatment of macular edema due to central retinal vein occlusion (CoRaLa II trial)Macular edema due to central retinal vein occlusionMedDRA version: 20.0Level: LLTClassification code: 10007972Term: Central retinal vein occlusion Class: 10015919MedDRA version: 20.0Level: LLTClassification code: 10054467Term: Macular edema Class: 10015919CTIS2023-507816-11-00Justus-Liebig-Universitaet Giessen110
进行中（未招募）
1 期
ong-term need of the drug ranibizumab applied as injection into the eye with or without early targeted peripheral laser photocoagulation of the retina for treatment of macular edema due to central retinal vein occlusioEUCTR2020-000681-42-DEJustus-Liebig University Gießen110
进行中（未招募）
1 期
ong-term need of the drug ranibizumab applied as injection into the eye with or without early targeted peripheral laser photocoagulation of the retina for treatment of macular edema due to central retinal vein occlusioMacular edema due to central retinal vein occlusionMedDRA version: 20.0Level: LLTClassification code 10054467Term: Macular edemaSystem Organ Class: 100000004853MedDRA version: 20.0Level: LLTClassification code 10007972Term: Central retinal vein occlusionSystem Organ Class: 100000004853EUCTR2020-000681-42-ATJustus-Liebig University Gießen110
尚未招募
不适用
Establishment of a proper use of ranibizumab for the macular edema in retinal vein occlusioRetinal vein occlusionJPRN-UMIN000012188Departmant of opthalmology,Kansai Medical University50
已完成
不适用
Comparison of inravitreal ranibizumab therapy with and without laser photocoagulation for diabetic macular edema.diabetic macular edemaJPRN-UMIN000024697Tokyo Women's Medical University100